Somite AI
PrivateLast Round
Strategic
Aug 20, 2025
Total Funding Raised
$57.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Somite AI is a biotechnology company developing an AI-driven platform, DeltaStem, to improve the production of human cells for therapeutic use in treating diseases like Type 1 Diabetes, orthopedic injuries, and muscular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Somite AI Comparables
Compare Somite AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mogrify | 83% | |
| Insilico Medicine | 69% | |
| Insitro | 68% |
Somite AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 20, 2025 | ||||
| Series A | May 13, 2025 | ||||
| Pre Seed | Sep 3, 2024 | ||||
| Pre Seed | Apr 16, 2024 |
Key People
Founding team and executive leadership
Somite AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Series A |
| SciFi Ventures | Series A |
| Khosla Ventures | Series A |
| TechAviv | Series A, Pre Seed |
| Montage Ventures | Pre Seed |
| Next Coast Ventures | Pre Seed |
| AMD Ventures | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 95% MoM.
- Jul 6, 2026
Grew 60% QoQ, from 57 to 91 employees.
Somite AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Somite AI's valuation, stock price, and market status.
Is Somite AI a public or private company?
Somite AI is a private company.
What is the current stock price of Somite AI?
Somite AI is a private company, so its shares have no public market price. Caplight tracks Somite AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Somite AI worth (valuation)?
Valuation information for Somite AI is not publicly available.
Can I buy Somite AI stock?
Somite AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Somite AI's last funding round?
Somite AI's most recent funding round was Strategic on August 20, 2025.
Who are the main investors in Somite AI?
Key investors in Somite AI include Khosla Ventures, TechAviv, Montage Ventures, AMD Ventures, Astellas Venture Management.
Will Somite AI IPO soon?
No public IPO plans have been announced for Somite AI.
How can I track Somite AI secondary market activity?
Caplight tracks bids, offers, and trades in Somite AI's shares on secondary markets.